PASITHEA THERAPEUTICS CORP. (KTTA) Stock buybacks

PASITHEA THERAPEUTICS CORP. (KTTA) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.

$3.7MFY2024

Fiscal year	Value	YoY
FY2024	$3.7M	—

Source: SEC XBRL filings · For reference only · Not investment advice

More KTTA financial trends

KTTA Revenue KTTA Net income KTTA Net margin KTTA Gross profit KTTA Gross margin KTTA Operating income KTTA Operating margin KTTA Operating cash flow KTTA Free cash flow KTTA Capital expenditures KTTA Return on equity KTTA Dividends paid KTTA Total assets KTTA Total liabilities KTTA Shareholders’ equity KTTA overview →